IXDEX. 773 



PAQK 



700: virus, tilterability of, 27, 698; rims /Ijre, 

 700. 705 : virus, resistance of, 609. 



lehthyosistuus ................. . .................. 420 



lehth'yotoxin ..................................... 432 



Immunity. 



Absolute. 135; acquired. 129. 161-175; active, 134. 

 antibacterial. 132, 149. 154, 355; anti- 

 toxic. 132. 154, 155, 354; definition of, 128; in 

 families, 130: leucocytes, relation to; see Phago- 

 cvtosis; natural, 129, 137-160; early theories of, 

 l"; passive, 134. 169; relative. 134; theories of. 7, 

 12: typos of. 135; see Antitoxins. Bacteriolysius. 

 Phagocytosis and the individual diseases. 



Immunization. 



Active. a curative measure, 364; active, for prophyl- 



axis. 376; classification of methods. 362; choice 



of animals for, 373 ; mixed. 364. 37 S : passive, as 



curative measure, 364 ; passive, in prophylaxsis. 



with tissue colls. 294: with toxins, 10. 



Impetigo contagiosa. 



Staphyloeoccns in. .~2> : streptococcus in. 



Incubation period ................................ 354 



Infection. 



Air borne." 19; atrium of, 19, 137. 141: carriers. 



out act by, 19; mixed. 20. 30. 31. --T - 

 iiulividnal diseases : "water borne." 19 ; infectious 

 agents, classification of, 21. 



Infeeuousness and contagiousness ................... 18 



Infociivity ............ '. .......................... 88 



Infestation ....................................... 14 



Inflammation. 



Antagonism of. to infections, 148; chemotaxis. 140: 

 connective tissue, inflammatory rdle of, 143. 148 : 

 fibrin, influence of. 148; injurious effects of, 143. 

 144 : leucocytes in. 145, 147 : nature of. 143 ; organi- 

 zation in, 147 ; phagocytosis in, 145-147 ; plasma. 

 influence of, 147 ; relation of, to virulence of bac- 

 teria. 144. 145: r61e of, in immunity and resist 

 ance, 143; variations in intensity. 144-146. 



Influenza .................................. 25, 563-569 



ronjunctivitis in. 507 : chronic. 507 : contagiousness 

 of 50o : epidemics of. 503 : immunity. 568: infec- 

 tion atrium. 567: intestinal. 566; intoxication, 

 meningitis in. 500. 507: mixed and secondary 

 infections in. 507: otitis media in, 566, 567; peri- 

 tonitis in. 500. 507 : phagocytosis in. 566 : pneumonia 

 during. 510. 500: prophylaxis. 568: recurrence of, 

 161, 568 ptihility. 508: transmission of, 567; 



tuberculosis during. 507 : see Bacillus i/fMir. 



In transmission. 67: incubation in. 81. 

 "Intestinal group" of bacteria ...................... 434 



Intoxication ...................................... 96 



Iso-agglutinins .................................... 218 



Isoprecipitins .................................. 



Kala-Amar ........................................ 696 



Lactoserum ................................... - 



LainblM iHlcs1inli# ............................... 004 



l.eischman Donovan Bodies : See Kala-Atar. 

 "Leistungskern** ............................... 209, 339 



Lecithin as endocomplement ....................... 



"Leprolin" ....................................... 621 



